# Ciprofol EC50 for Inducing Loss of Consciousness in Elderly Patients

> **NCT06253078** · PHASE4 · RECRUITING · sponsor: **Zhejiang Cancer Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Elderly Patients

## Interventions

- **DRUG:** Ciprofol dose 0.4mg/Kg
- **DRUG:** Ciprofol dose 0.3mg/Kg
- **DRUG:** Ciprofol dose 0.2mg/Kg

## Key facts

- **NCT ID:** NCT06253078
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-02
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06253078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06253078, "Ciprofol EC50 for Inducing Loss of Consciousness in Elderly Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06253078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*